Table 1 Basic characteristics of ND-AML patients between NK% high and NK% low in BM

Age, years

ns

 Median

47

 Range

15–78

19–74

Gender, no. (%)

ns

 Male

20 (58.8%)

16 (45.7%)

 Female

14 (41.2%)

19 (54.3%)

Hepatic or renal function, no.^a

ns

 Normal

32

32

 Abnormal

2

3

WBC, 10⁹/L

ns

 Median

10.665

13.79

 Range

1–249.98

1.4–371.9

Platelet, 10⁹/L

ns

 Median

34.5

28

 Range

1.87–401

3–167

56

HB, g/L

ns

 Median

81

74

 Range

20–116

52–149

PB NK, %

< 0.001

 Median

14.1

5.4

 Range

4.2–42.9

2.3–21.7

BM blasts, %

ns

 Median

53.7

53.1

 Range

6.6–94.1

16.3–95.1

BM Lymph, %

ns

 Median

11.3

6.2

 Range

2.2–49

1.7–49.2

BM NK, %

< 0.001

 Median

19.65

7.6

 Range

12.5–43.6

2–11.9

BM T, %

< 0.001

 Median

66.5

77.7

 Range

45.6–80.4

46–86.2

 t(15;17)/PML-RARA

0

0

 t(8;21)/AML1-ETO

1

4

 inv.(16;16)/CBFb-MYH11

2

1

 CN-AML^b

23

22

 Unfavorable^c

8

8

 FLT3 mutations

15

5

 RAS mutations

6

6